Canada-based eMurmur has been granted US Food and Drug Administration approval for its cloud and mobile-based AI platform that detects heart murmurs. A recording from a third-party digital stethoscope is uploaded via eMurmur's app to a HIPAA-compliant server, where it is analysed against a database of sounds and cardiologist notes. The company said its app has a success rate of 25% to 30%, compared with traditional levels of between 85% and 90%, and it is using educational programmes to encourage widespread adoption.
Canada-based eMurmur has been granted US Food and Drug Administration approval for its cloud and mobile-based AI platform that detects heart murmurs. A recording from a third-party digital stethoscope is uploaded via eMurmur's app to a HIPAA-compliant server, where it is analysed against a database of sounds and cardiologist notes. The company said its app has a success rate of between 85% and 90%, compared with traditional levels of 25% to 30%, and it is using educational programmes to encourage widespread adoption.